Giving aspirin and ibuprofen after myocardial infarction
- PMID: 14656809
- PMCID: PMC286284
- DOI: 10.1136/bmj.327.7427.1298
Giving aspirin and ibuprofen after myocardial infarction
Comment on
-
Aspirin, ibuprofen, and mortality after myocardial infarction: retrospective cohort study.BMJ. 2003 Dec 6;327(7427):1322-3. doi: 10.1136/bmj.327.7427.1322. BMJ. 2003. PMID: 14656840 Free PMC article. No abstract available.
Similar articles
-
Aspirin, ibuprofen, and mortality after myocardial infarction: retrospective cohort study.BMJ. 2003 Dec 6;327(7427):1322-3. doi: 10.1136/bmj.327.7427.1322. BMJ. 2003. PMID: 14656840 Free PMC article. No abstract available.
-
My doctor recently recommended that I take low-dose aspirin to minimize the risk of a heart attack or stroke. I routinely take ibuprofen for arthritis pain. Do I need both, and is it safe to combine the two?Health News. 2000 Jan;6(1):10. Health News. 2000. PMID: 11019669 No abstract available.
-
Ibuprofen may abrogate the benefits of aspirin when used for secondary prevention of myocardial infarction.J Rheumatol. 2005 Aug;32(8):1589-93. J Rheumatol. 2005. PMID: 16078339
-
Aspirin and its rivals. As your options increase, your choices get harder.Harv Mens Health Watch. 2002 Dec;7(5):1-5. Harv Mens Health Watch. 2002. PMID: 12499131 Review. No abstract available.
-
High on treatment platelet reactivity against aspirin by non-steroidal anti-inflammatory drugs--pharmacological mechanisms and clinical relevance.Thromb Haemost. 2013 May;109(5):825-33. doi: 10.1160/TH12-07-0532. Epub 2012 Dec 13. Thromb Haemost. 2013. PMID: 23238666 Review.
Cited by
-
Aspirin, NSAIDs, and COX-2 inhibitors in cardiovascular disease: possible interactions and implications for treatment of rheumatoid arthritis.Curr Rheumatol Rep. 2004 Oct;6(5):351-6. doi: 10.1007/s11926-004-0009-0. Curr Rheumatol Rep. 2004. PMID: 15355747 Review.
-
Cardiology.Br J Gen Pract. 2004 Sep;54(506):695-702. Br J Gen Pract. 2004. PMID: 15353058 Free PMC article. Review.
-
Interference of NSAIDs with the thrombocyte inhibitory effect of aspirin: a placebo-controlled, ex vivo, serial placebo-controlled serial crossover study.Eur J Clin Pharmacol. 2013 Mar;69(3):365-71. doi: 10.1007/s00228-012-1370-y. Epub 2012 Aug 14. Eur J Clin Pharmacol. 2013. PMID: 22890587 Clinical Trial.
References
-
- Patrono C. Aspirin as an antiplatelet drug. N Engl J Med 1994;330: 1287-93. - PubMed
-
- Lauer MS. Clinical practice. Aspirin for primary prevention of coronary events. N Engl J Med 2002;346: 1468-74. - PubMed
-
- Catella-Lawson F, Reilly MP, Kapoor SC, Cucchiara AJ, DeMarco S, Tournier B, et al. Cyclooxygenase inhibitors and the antiplatelet effects of aspirin. N Engl J Med 2001;345: 1809-17. - PubMed
-
- Stiel D. Exploring the link between gastrointestinal complications and over-the-counter analgesics: current issues and considerations. Am J Ther 2000;7: 91-8. - PubMed
-
- Wilcox CM, Shalek KA, Cotsonis G. Striking prevalence of over-the-counter nonsteroidal anti-inflammatory drug use in patients with upper gastrointestinal hemorrhage. Arch Intern Med 1994;154: 42-6. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical